170 related articles for article (PubMed ID: 11408768)
1. Effect of emedastine difumarate on CC chemokine-elicited eosinophil migration.
Saito H; Yamamoto N; Tomita S; Taniguchi M; Hasegawa M; Akiyama K; Kawaguchi H; Takahashi K
Int Arch Allergy Immunol; 2001; 125 Suppl 1():22-8. PubMed ID: 11408768
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
[TBL] [Abstract][Full Text] [Related]
3. Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo.
Marleau S; Griffiths-Johnson DA; Collins PD; Bakhle YS; Williams TJ; Jose PJ
J Immunol; 1996 Nov; 157(9):4141-6. PubMed ID: 8892650
[TBL] [Abstract][Full Text] [Related]
4. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
Shahabuddin S; Ponath P; Schleimer RP
J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
el-Shazly AE; Masuyama K; Samejima Y; Eura M; Ishikawa T
Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):587-95. PubMed ID: 8933171
[TBL] [Abstract][Full Text] [Related]
6. The CC chemokine receptor antagonist met-RANTES inhibits eosinophil effector functions.
Elsner J; Petering H; Kimmig D; Wells TN; Proudfoot AE; Kapp A
Int Arch Allergy Immunol; 1999; 118(2-4):462-5. PubMed ID: 10224475
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.
Ponath PD; Qin S; Post TW; Wang J; Wu L; Gerard NP; Newman W; Gerard C; Mackay CR
J Exp Med; 1996 Jun; 183(6):2437-48. PubMed ID: 8676064
[TBL] [Abstract][Full Text] [Related]
8. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils.
Elsner J; Höchstetter R; Kimmig D; Kapp A
Eur J Immunol; 1996 Aug; 26(8):1919-25. PubMed ID: 8765040
[TBL] [Abstract][Full Text] [Related]
9. Cloning, expression, and characterization of the human eosinophil eotaxin receptor.
Daugherty BL; Siciliano SJ; DeMartino JA; Malkowitz L; Sirotina A; Springer MS
J Exp Med; 1996 May; 183(5):2349-54. PubMed ID: 8642344
[TBL] [Abstract][Full Text] [Related]
10. Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells.
Umland SP; Wan Y; Shortall J; Shah H; Jakway J; Garlisi CG; Tian F; Egan RW; Billah MM
J Leukoc Biol; 2000 Mar; 67(3):441-7. PubMed ID: 10733106
[TBL] [Abstract][Full Text] [Related]
11. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
[TBL] [Abstract][Full Text] [Related]
12. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines.
Stellato C; Collins P; Ponath PD; Soler D; Newman W; La Rosa G; Li H; White J; Schwiebert LM; Bickel C; Liu M; Bochner BS; Williams T; Schleimer RP
J Clin Invest; 1997 Mar; 99(5):926-36. PubMed ID: 9062350
[TBL] [Abstract][Full Text] [Related]
13. Novel association of the src family kinases, hck and c-fgr, with CCR3 receptor stimulation: A possible mechanism for eotaxin-induced human eosinophil chemotaxis.
El-Shazly A; Yamaguchi N; Masuyama K; Suda T; Ishikawa T
Biochem Biophys Res Commun; 1999 Oct; 264(1):163-70. PubMed ID: 10527858
[TBL] [Abstract][Full Text] [Related]
14. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.
Ponath PD; Qin S; Ringler DJ; Clark-Lewis I; Wang J; Kassam N; Smith H; Shi X; Gonzalo JA; Newman W; Gutierrez-Ramos JC; Mackay CR
J Clin Invest; 1996 Feb; 97(3):604-12. PubMed ID: 8609214
[TBL] [Abstract][Full Text] [Related]
15. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
[TBL] [Abstract][Full Text] [Related]
16. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
White JR; Lee JM; Dede K; Imburgia CS; Jurewicz AJ; Chan G; Fornwald JA; Dhanak D; Christmann LT; Darcy MG; Widdowson KL; Foley JJ; Schmidt DB; Sarau HM
J Biol Chem; 2000 Nov; 275(47):36626-31. PubMed ID: 10969084
[TBL] [Abstract][Full Text] [Related]
17. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
Sabroe I; Hartnell A; Jopling LA; Bel S; Ponath PD; Pease JE; Collins PD; Williams TJ
J Immunol; 1999 Mar; 162(5):2946-55. PubMed ID: 10072545
[TBL] [Abstract][Full Text] [Related]
19. Delayed production of biologically active O-glycosylated forms of human eotaxin by tumor-necrosis-factor-alpha-stimulated dermal fibroblasts.
Noso N; Bartels J; Mallet AI; Mochizuki M; Christophers E; Schröder JM
Eur J Biochem; 1998 Apr; 253(1):114-22. PubMed ID: 9578468
[TBL] [Abstract][Full Text] [Related]
20. Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate.
El-Shazly A; Masuyama K; Samejima Y; Eura M; Ishikawa T
Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():10-3. PubMed ID: 9758889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
